HAVING A BALANCED MIX OF ONLINE & IN-PERSON MENTORING, PROFESSIONAL DEVELOPMENT AND SECOND OPINIONS
With
Dr Kieran Richardson (FACP)
Specialist Musculoskeletal Physiotherapist &
Director, Global Specialist Physiotherapy Pty Ltd
PEOPLE IN HEALTH CARE SEGMENT
Filmed in Perth | October 2025
Dr. Kieran Richardson (FACP) is a Specialist Physiotherapist, conferred by the Australian College of Physiotherapists (Australian Physiotherapy Association) in 2016.
Dr Richardson is the Director of Global Specialist Physiotherapy, a consultancy company providing online Formal Mentoring and Professional Development individual clinicians, clinics, and groups, as well as Second Opinions to clinicians and directly to patients all around the world.
He has presented in state, national and international conferences, and has a special interest in evidence-based, non-surgical management of musculoskeletal conditions and recognition of these strategies within the Physiotherapy profession, as well as interprofessionally and to the general public.
Since the COVID-19 pandemic, his clinical role within Global Specialist Physiotherapy has shifted, whereby now he and his team offer primarily telehealth non-surgical second opinion consultations for patients with pain and injury locally in Australia and around the world.
He has conducted research into the biopsychosocial nature of musculoskeletal pain and injury, online information about the management of anterior cruciate ligament ruptures in Australia and is currently a part of an expert group of clinicians assisting the Australian Knee Injury Study through La Trobe University in Victoria.
Source: Supplied
-
Ruth Zionzee – Distinguished Life Fellow
ACN Ruth Zionzee – Distinguished Life Fellow
-
Foundation outlines breast cancer research strategy
Australian Health Journal met with Associate Professor Cleola Anderiesz, CEO of the National Breast Cancer Foundation to hear of the new 5 year Pink Horizon research strategy. Those with lived experience of breast cancer, along with researchers, clinicians, and other funding organisations, have contributed to the development of the foundation’s new five-year Pink Horizon research strategy. This ambitious plan aims to invest $125 million to accelerate research efforts towards the vision of ending deaths from breast cancer.
-
Clinical research integrates with GP and Pharmacist workflows to supplement practice revenue
Clinical trials are crucial to the development of evidence-based preventative medicines. In addition, participation in clinical trials can also provide patients with opportunities to access new treatments.
“Clinical trials are at the heart of medical advances which look into new ways to treat, prevent, or detect disease. Volunteers often do so to help contribute to advancing scientific research, knowing that they are participating in the hope of helping future generations,” said Charlotte Bradshaw, CEO and Founder to Evrima Technologies.
